Bengaluru: Bladeless windmills, reusable plant-fibre packaging, textile waste upcycling, and sustainability credit scores ...

USA News Group - News Commentary - Depression remains one of the most stubborn problems in modern medicine, and the numbers ...

Two genomics ETFs share the same buzzwords on every screener, but their structures have sent them on wildly different paths ...

Gujarat has confirmed 12 cases of Chandipura virus (CHPV) from 63 suspected infections reported so far this year, with eight ...

The former Rhode Island anesthesiologist who spent more than 20 years on the run to avoid being prosecuted on sexual assault ...

Defaults on student loans have surged across the United States, reaching record levels as borrowers struggle to keep up with ...

Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

Valdosta State University has announced the members of its graduating class of Spring 2026, including the following list of area residents. Area graduates include:  Helen Allen of Adel […] ...

Claude is bullish on the stock because the price has not caught up to the company’s earnings turnaround, according to “The ...

ACTiVION-II, the first of two US Phase 3 clinical trials, did not meet co-primary endpoints of VAS pain score and WOMAC total score at Month 12Results from ACTiVION-I, the second Phase 3 trial of TG-C ...

Here's a look at some local developments that underscore the opportunities and challenges that lie ahead for Massachusetts.

Billionaire Steve Cohen still backs biotech Evommune despite trial setbacks, highlighting its potential for treating chronic ...